{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:01Z","timestamp":1793299141807,"version":"4.5.0"},"reference-count":159,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"Renalytix","award":["unrestricted educational grant"],"award-info":[{"award-number":["unrestricted educational grant"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:p>More than one-third of people with diabetes develop diabetic kidney disease (DKD), which substantially increases risks of kidney failure, cardiovascular disease (CVD), hypoglycemia, death, and other adverse health outcomes. A multifaceted approach incorporating self-management education, lifestyle optimization, pharmacological intervention, CVD prevention, and psychosocial support is crucial to mitigate the onset and progression of DKD. The American Diabetes Association convened an expert panel to develop the DKD Prevention Model presented herein. This model addresses prevention and treatment, including screening guidelines, diagnostic tools, and management approaches; comprehensive, holistic interventions; well-defined roles for interdisciplinary health care professionals; community engagement; and future directions for research and policy.<\/jats:p>","DOI":"10.2337\/cd23-0063","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T15:30:51Z","timestamp":1701876651000},"page":"274-294","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":18,"title":["Diabetic Kidney Disease Prevention Care Model Development"],"prefix":"10.2337","volume":"42","author":[{"given":"Nuha A.","family":"ElSayed","sequence":"first","affiliation":[{"name":"1American Diabetes Association, Alexandria, VA"},{"name":"2Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8069-5783","authenticated-orcid":false,"given":"Raveendhara R.","family":"Bannuru","sequence":"additional","affiliation":[{"name":"1American Diabetes Association, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Bakris","sequence":"additional","affiliation":[{"name":"3Department of Medicine, American Heart Association Comprehensive Hypertension Center, University of Chicago School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bardsley","sequence":"additional","affiliation":[{"name":"4MedStar Health Research Institute and MedStar System Nursing, Columbia, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1571-7592","authenticated-orcid":false,"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[{"name":"5Division of Nephrology, University of Washington School of Medicine, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Gabbay","sequence":"additional","affiliation":[{"name":"1American Diabetes Association, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Gockerman","sequence":"additional","affiliation":[{"name":"6St. Mark\u2019s Episcopal Church, Grand Rapids, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[{"name":"7Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, University of Maryland School of Medicine, University of Maryland Institute for Health Computing, Rockville, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"McCracken","sequence":"additional","affiliation":[{"name":"1American Diabetes Association, Alexandria, VA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4734-7402","authenticated-orcid":false,"given":"Joshua J.","family":"Neumiller","sequence":"additional","affiliation":[{"name":"8College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA"},{"name":"9Providence Medical Research Center, Providence Health Care, Spokane, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9047","authenticated-orcid":false,"given":"Scott J.","family":"Pilla","sequence":"additional","affiliation":[{"name":"10Department of Medicine, Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-6469","authenticated-orcid":false,"given":"Connie M.","family":"Rhee","sequence":"additional","affiliation":[{"name":"11Division of Nephrology, Hypertension, and Kidney Transplantation, University of California Irvine School of Medicine, Irvine, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,12,6]]},"reference":[{"key":"2024041518510062300_B1","author":"Centers for Disease Control and Prevention"},{"key":"2024041518510062300_B2","volume-title":"2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States.","author":"United States Renal Data System","year":"2021"},{"key":"2024041518510062300_B3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"2024041518510062300_B4","author":"Centers for Disease Control and Prevention"},{"key":"2024041518510062300_B5","author":"Centers for Disease Control and Prevention"},{"key":"2024041518510062300_B6","first-page":"19","volume-title":"Chronic Kidney Disease and Type 2 Diabetes.","author":"Norris","year":"2021"},{"key":"2024041518510062300_B7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.2337\/dc21-0529","article-title":"Prescribing trends of antidiabetes medications in patients with type 2 diabetes and diabetic kidney disease: a cohort study","volume":"44","author":"Harris","year":"2021","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B8","doi-asserted-by":"crossref","first-page":"e1918169","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2024041518510062300_B9","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/diacare.28.9.2280","article-title":"Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review","volume":"28","author":"Lanting","year":"2005","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B10","doi-asserted-by":"crossref","first-page":"101S","DOI":"10.1177\/1077558707305409","article-title":"Diabetes health disparities: a systematic review of health care interventions","volume":"64","author":"Peek","year":"2007","journal-title":"Med Care Res Rev"},{"key":"2024041518510062300_B11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s11524-013-9861-4","article-title":"Racial disparities in diabetes mortality in the 50 most populous US cities","volume":"91","author":"Rosenstock","year":"2014","journal-title":"J Urban Health"},{"key":"2024041518510062300_B12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s11606-019-04843-9","article-title":"Primary care provides the majority of outpatient care for patients with diabetes in the US: NAMCS 2009\u20132015","volume":"34","author":"Pilla","year":"2019","journal-title":"J Gen Intern Med"},{"key":"2024041518510062300_B13","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2337\/dc23-S011","article-title":"11. Chronic kidney disease and risk management: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B14","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B15","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"2024041518510062300_B16","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.34067\/KID.0003962020","article-title":"Histopathologic and clinical features in patients with diabetes and kidney disease","volume":"1","author":"Sanghavi","year":"2020","journal-title":"Kidney360"},{"key":"2024041518510062300_B17","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.02510213","article-title":"The modern spectrum of renal biopsy findings in patients with diabetes","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041518510062300_B18","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2215\/CJN.03700417","article-title":"Diabetes and CKD in the United States population, 2009\u20132014","volume":"12","author":"Zelnick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041518510062300_B19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2020.08.039","article-title":"Rationale and design of the Kidney Precision Medicine Project","volume":"99","author":"de Boer","year":"2021","journal-title":"Kidney Int"},{"key":"2024041518510062300_B20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"Kidney Disease: Improving Global Outcomes Diabetes Work Group","year":"2020","journal-title":"Kidney Int"},{"key":"2024041518510062300_B21","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"key":"2024041518510062300_B22","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2021010039","article-title":"Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN Task Force","volume":"32","author":"Delgado","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024041518510062300_B23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/j.ajkd.2021.03.008","article-title":"Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN Task Force","volume":"78","author":"Delgado","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B24","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.ajkd.2021.08.003","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease","volume":"79","author":"Delgado","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B25","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1681\/ASN.2021070988","article-title":"A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease","volume":"32","author":"Delgado","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2024041518510062300_B26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B27","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2337\/dc23-S005","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B28","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/dci20-0023","article-title":"Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association","volume":"43","author":"Powers","year":"2020","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B29","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1001\/jama.2020.17108","article-title":"Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"324","author":"O\u2019Connor","year":"2020","journal-title":"JAMA"},{"key":"2024041518510062300_B30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/M14-2238","article-title":"Efficacy of commercial weight-loss programs: an updated systematic review","volume":"162","author":"Gudzune","year":"2015","journal-title":"Ann Intern Med"},{"key":"2024041518510062300_B31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"2024041518510062300_B32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00125-017-4473-2","article-title":"Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)","volume":"61","author":"Agrawal","year":"2018","journal-title":"Diabetologia"},{"key":"2024041518510062300_B33","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJMoa1407963","article-title":"Follow-up of blood-pressure lowering and glucose control in type 2 diabetes","volume":"371","author":"Zoungas","year":"2014","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B34","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"2024041518510062300_B36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-8587(14)70155-X","article-title":"Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study","volume":"2","author":"DCCT\/EDIC Research Group","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024041518510062300_B37","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"DCCT\/EDIC Research Group","year":"2011","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B38","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic targets: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B39","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B40","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2215\/CJN.02850315","article-title":"BP and renal outcomes in diabetic kidney disease: the Veterans Affairs Nephropathy in Diabetes Trial","volume":"10","author":"Leehey","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041518510062300_B41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American Diabetes Association","volume":"40","author":"de Boer","year":"2017","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B42","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"2024041518510062300_B43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"2024041518510062300_B45","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.2337\/dci22-0027","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"45","author":"de Boer","year":"2022","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B46","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. Cardiovascular disease and risk management: Standards of Care in Diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B47","doi-asserted-by":"crossref","first-page":"i438","DOI":"10.1136\/bmj.i438","article-title":"Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials","volume":"352","author":"Bangalore","year":"2016","journal-title":"BMJ"},{"key":"2024041518510062300_B48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJMoa2200433","article-title":"Glycemia reduction in type 2 diabetes: glycemic outcomes","volume":"387","author":"GRADE Study Research Group","year":"2022","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B49","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B50","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B51","author":"Boehringer Ingelheim"},{"key":"2024041518510062300_B52","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"2024041518510062300_B55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2024041518510062300_B56","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B57","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"2024041518510062300_B59","author":"Bayer"},{"key":"2024041518510062300_B60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3122\/jabfm.2021.01.200187","article-title":"Interdisciplinary primary care team expertise and diabetes care management","volume":"34","author":"Miller-Rosales","year":"2021","journal-title":"J Am Board Fam Med"},{"key":"2024041518510062300_B61","first-page":"21","article-title":"The interdisciplinary team in type 2 diabetes management: challenges and best practice solutions from real-world scenarios","volume":"7","author":"McGill","year":"2016","journal-title":"J Clin Transl Endocrinol"},{"key":"2024041518510062300_B62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13643-018-0748-z","article-title":"Effectiveness of self-management support interventions for people with comorbid diabetes and chronic kidney disease: a systematic review and meta-analysis","volume":"7","author":"Zimbudzi","year":"2018","journal-title":"Syst Rev"},{"key":"2024041518510062300_B63","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1370\/afm.2553","article-title":"Enhanced care team nurse process to improve diabetes care","volume":"18","author":"Herges","year":"2020","journal-title":"Ann Fam Med"},{"key":"2024041518510062300_B64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2337\/cd23-as01","article-title":"Standards of Care in Diabetes\u20142023 abridged for primary care providers","volume":"41","author":"American Diabetes Association","year":"2022","journal-title":"Clin Diabetes"},{"key":"2024041518510062300_B65","author":"Centers for Disease Control and Prevention"},{"key":"2024041518510062300_B66","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/phar.2083","article-title":"Pharmacist intervention for blood pressure control in patients with diabetes and\/or chronic kidney disease","volume":"38","author":"Anderegg","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2024041518510062300_B67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12882-016-0383-7","article-title":"Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study","volume":"17","author":"Chang","year":"2016","journal-title":"BMC Nephrol"},{"key":"2024041518510062300_B68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/jcpt.13262","article-title":"Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: a meta-analysis of randomized clinical trials","volume":"46","author":"Nakanishi","year":"2021","journal-title":"J Clin Pharm Ther"},{"key":"2024041518510062300_B69","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/MNH.0b013e328365b364","article-title":"New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management","volume":"22","author":"St Peter","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2024041518510062300_B70","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1093\/ajhp\/zxab271","article-title":"Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: an opportunity for pharmacists","volume":"79","author":"Neumiller","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"2024041518510062300_B71","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/j.ackd.2021.02.001","article-title":"Overcoming barriers to implementing new therapies for diabetic kidney disease: lessons learned","volume":"28","author":"Neumiller","year":"2021","journal-title":"Adv Chronic Kidney Dis"},{"key":"2024041518510062300_B72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0897190019876499","article-title":"A pilot study embedding clinical pharmacists within an interprofessional nephrology clinic for the initiation and monitoring of empagliflozin in diabetic kidney disease","volume":"34","author":"Triantafylidis","year":"2021","journal-title":"J Pharm Pract"},{"key":"2024041518510062300_B73","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.5888\/pcd10.120180","article-title":"The chronic care model and diabetes management in US primary care settings: a systematic review","volume":"10","author":"Stellefson","year":"2013","journal-title":"Prev Chronic Dis"},{"key":"2024041518510062300_B74","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0272-6386(03)00405-0","article-title":"Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP)","volume":"42","author":"Brown","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B75","author":"National Kidney Foundation"},{"key":"2024041518510062300_B76","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ki.2013.369","article-title":"Educational programs improve the preparation for dialysis and survival of patients with chronic kidney disease","volume":"85","author":"Kurella Tamura","year":"2014","journal-title":"Kidney Int"},{"key":"2024041518510062300_B77","author":"National Kidney Foundation"},{"key":"2024041518510062300_B78","author":"World Kidney Day"},{"key":"2024041518510062300_B79","author":"National Kidney Foundation"},{"key":"2024041518510062300_B80","author":"National Kidney Foundation"},{"key":"2024041518510062300_B81","author":"National Kidney Foundation"},{"key":"2024041518510062300_B82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2017.12.016","article-title":"Social determinants of health: addressing unmet needs in nephrology","volume":"72","author":"Hall","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B83","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1681\/ASN.2016010027","article-title":"Social determinants of racial disparities in CKD","volume":"27","author":"Norton","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2024041518510062300_B84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.ackd.2014.07.002","article-title":"Socioeconomic disparities in chronic kidney disease","volume":"22","author":"Nicholas","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"2024041518510062300_B85","doi-asserted-by":"crossref","first-page":"100381","DOI":"10.1016\/j.xkme.2021.08.015","article-title":"Racial and socioeconomic disparities in CKD in the context of universal health care provided by the military health system","volume":"4","author":"Norton","year":"2021","journal-title":"Kidney Med"},{"key":"2024041518510062300_B86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000688","article-title":"Disparities in chronic kidney disease: the state of the evidence","volume":"30","author":"Clark-Cutaia","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2024041518510062300_B87","doi-asserted-by":"crossref","first-page":"e207932","DOI":"10.1001\/jamanetworkopen.2020.7932","article-title":"National trends in the prevalence of chronic kidney disease among racial\/ethnic and socioeconomic status groups, 1988\u20132016","volume":"3","author":"Vart","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024041518510062300_B88","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.pmedr.2019.100850","article-title":"Racial\/ethnic disparities in prevalence, treatment, and control of hypertension among US adults following application of the 2017 American College of Cardiology\/American Heart Association guideline","volume":"14","author":"Al Kibria","year":"2019","journal-title":"Prev Med Rep"},{"key":"2024041518510062300_B89","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amepre.2014.11.004","article-title":"Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis","volume":"48","author":"Vart","year":"2015","journal-title":"Am J Prev Med"},{"key":"2024041518510062300_B90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ajkd.2016.10.035","article-title":"Food insecurity, CKD, and subsequent ESRD in US adults","volume":"70","author":"Banerjee","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11892-018-0980-x","article-title":"The landscape of diabetic kidney disease in the United States","volume":"18","author":"Duru","year":"2018","journal-title":"Curr Diab Rep"},{"key":"2024041518510062300_B92","first-page":"CD011207","article-title":"Community pharmacy interventions for health promotion: effects on professional practice and health outcomes","volume":"12","author":"Steed","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2024041518510062300_B93","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.5888\/pcd14.160409","article-title":"A project to promote adherence to blood pressure medication among people who use community pharmacies in rural Montana, 2014\u20132016","volume":"14","author":"Oser","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"2024041518510062300_B94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.gheart.2016.07.001","article-title":"The effectiveness of community health workers for CVD prevention in LMIC","volume":"12","author":"Khetan","year":"2017","journal-title":"Glob Heart"},{"key":"2024041518510062300_B95","doi-asserted-by":"crossref","first-page":"e0180640","DOI":"10.1371\/journal.pone.0180640","article-title":"Community health workers for non-communicable diseases prevention and control in developing countries: evidence and implications","volume":"12","author":"Jeet","year":"2017","journal-title":"PLoS One"},{"key":"2024041518510062300_B96","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.2105\/AJPH.2015.302987","article-title":"Effects of community-based health worker interventions to improve chronic disease management and care among vulnerable populations: a systematic review","volume":"106","author":"Kim","year":"2016","journal-title":"Am J Public Health"},{"key":"2024041518510062300_B97","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s11606-015-3247-0","article-title":"Community health worker interventions to improve glycemic control in people with diabetes: a systematic review and meta-analysis","volume":"30","author":"Palmas","year":"2015","journal-title":"J Gen Intern Med"},{"key":"2024041518510062300_B98","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/dc17-0978","article-title":"Outcomes at 18 months from a community health worker and peer leader diabetes self-management program for Latino adults","volume":"41","author":"Spencer","year":"2018","journal-title":"Diabetes Care"},{"key":"2024041518510062300_B99","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1037\/fsh0000283","article-title":"Community health workers in diabetes care: a systematic review of randomized controlled trials","volume":"35","author":"Trump","year":"2017","journal-title":"Fam Syst Health"},{"key":"2024041518510062300_B100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1353\/hpu.2016.0192","article-title":"What is the potential of community paramedicine to fill rural health care gaps?","volume":"27","author":"Patterson","year":"2016","journal-title":"J Health Care Poor Underserved"},{"key":"2024041518510062300_B101","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/ds21-0095","article-title":"Diabetes management for community paramedics: development and implementation of a novel curriculum","volume":"35","author":"Kasper","year":"2022","journal-title":"Diabetes Spectr"},{"key":"2024041518510062300_B102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/pop.2018.0114","article-title":"Systematic review of community paramedicine and EMS mobile integrated health care interventions in the United States","volume":"22","author":"Gregg","year":"2019","journal-title":"Popul Health Manag"},{"key":"2024041518510062300_B103","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.1111\/jrh.12233","article-title":"Community paramedicine applied in a rural community","volume":"34","author":"Bennett","year":"2018","journal-title":"J Rural Health"},{"key":"2024041518510062300_B104","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1111\/1475-6773.12855","article-title":"Home visit-based community paramedicine and its potential role in improving patient-centered primary care: a grounded theory study and framework","volume":"53","author":"Dainty","year":"2018","journal-title":"Health Serv Res"},{"key":"2024041518510062300_B105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.evalprogplan.2015.11.001","article-title":"Utilizing health ambassadors to improve type 2 diabetes and cardiovascular disease outcomes in Gadsden County, Florida","volume":"55","author":"Suther","year":"2016","journal-title":"Eval Program Plann"},{"key":"2024041518510062300_B106","first-page":"3601","article-title":"Peer support for people with chronic conditions in rural areas: a scoping review","volume":"16","author":"Lauckner","year":"2016","journal-title":"Rural Remote Health"},{"key":"2024041518510062300_B107","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/1472-6963-13-533","article-title":"Telephone based self-management support by \u2018lay health workers\u2019 and \u2018peer support workers\u2019 to prevent and manage vascular diseases: a systematic review and meta-analysis","volume":"13","author":"Small","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"2024041518510062300_B108","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40842-017-0042-3","article-title":"Peer support of complex health behaviors in prevention and disease management with special reference to diabetes: systematic reviews","volume":"3","author":"Fisher","year":"2017","journal-title":"Clin Diabetes Endocrinol"},{"key":"2024041518510062300_B109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.pcd.2018.11.007","article-title":"Effectiveness of peer led intervention in improvement of clinical outcomes among diabetes mellitus and hypertension patients: a systematic review and meta-analysis","volume":"13","author":"Krishnamoorthy","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"2024041518510062300_B110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s40615-022-01299-2","article-title":"Participant perspectives on the effects of an African American faith-based health promotion educational intervention: a qualitative study","volume":"10","author":"Majee","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"key":"2024041518510062300_B111","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1177\/1359105317695878","article-title":"Preventing cardiovascular disease: participant perspectives of the FAITH! Program","volume":"24","author":"Brewer","year":"2019","journal-title":"J Health Psychol"},{"key":"2024041518510062300_B112","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0890117120958545","article-title":"Better Me within randomized trial: faith-based diabetes prevention program for weight loss in African American women","volume":"35","author":"Kitzman","year":"2021","journal-title":"Am J Health Promot"},{"key":"2024041518510062300_B113","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.numecd.2020.06.005","article-title":"Reducing metabolic syndrome through a community-based lifestyle intervention in African American women","volume":"30","author":"Mamun","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2024041518510062300_B114","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1007\/s40615-020-00740-8","article-title":"A multilevel diabetes and CVD risk reduction intervention in African American churches: Project Faith Influencing Transformation (FIT) feasibility and outcomes","volume":"7","author":"Berkley-Patton","year":"2020","journal-title":"J Racial Ethn Health Disparities"},{"key":"2024041518510062300_B115","first-page":"28","article-title":"Group coaching among African-American individuals with prediabetes in a faith-based setting","volume":"32","author":"Jackson","year":"2021","journal-title":"J Natl Black Nurses Assoc"},{"key":"2024041518510062300_B116","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s10943-014-9924-1","article-title":"The role and influence of faith leaders on health-related issues and programs in their congregation","volume":"54","author":"Baruth","year":"2015","journal-title":"J Relig Health"},{"key":"2024041518510062300_B117","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s10943-013-9702-5","article-title":"The role of religious leaders in promoting healthy habits in religious institutions","volume":"53","author":"Anshel","year":"2014","journal-title":"J Relig Health"},{"key":"2024041518510062300_B118","doi-asserted-by":"crossref","first-page":"321","DOI":"10.18865\/ed.27.S1.321","article-title":"Academic-community partnership development to enhance program outcomes in underserved communities: a case study","volume":"27","author":"Skizim","year":"2017","journal-title":"Ethn Dis"},{"key":"2024041518510062300_B119","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/phn.12222","article-title":"The evaluation of a regional faith community network\u2019s Million Hearts program","volume":"33","author":"Cooper","year":"2016","journal-title":"Public Health Nurs"},{"key":"2024041518510062300_B120","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/HYPERTENSIONAHA.106.080432","article-title":"Barbershops as hypertension detection, referral, and follow-up centers for black men","volume":"49","author":"Hess","year":"2007","journal-title":"Hypertension"},{"key":"2024041518510062300_B121","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1717250","article-title":"A cluster-randomized trial of blood-pressure reduction in Black barbershops","volume":"378","author":"Victor","year":"2018","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.118.038165","article-title":"Sustainability of blood pressure reduction in Black barbershops","volume":"139","author":"Victor","year":"2019","journal-title":"Circulation"},{"key":"2024041518510062300_B123","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/archinternmed.2010.390","article-title":"Effectiveness of a barber-based intervention for improving hypertension control in Black men: the BARBER-1 study: a cluster randomized trial","volume":"171","author":"Victor","year":"2011","journal-title":"Arch Intern Med"},{"key":"2024041518510062300_B124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1179\/1753807614Y.0000000050","article-title":"Lessons learned from the Black Cosmetologists Promoting Health program: a randomized controlled trial testing a diabetes education program","volume":"7","author":"Sadler","year":"2014","journal-title":"J Commun Healthc"},{"key":"2024041518510062300_B125","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jada.2010.03.012","article-title":"Beauty salon health intervention increases fruit and vegetable consumption in African-American women","volume":"110","author":"Johnson","year":"2010","journal-title":"J Am Diet Assoc"},{"key":"2024041518510062300_B126","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1136\/jech-2021-216515","article-title":"Behavioural interventions for CVD risk reduction for blue-collar workers: a systematic review","volume":"75","author":"Crane","year":"2021","journal-title":"J Epidemiol Community Health"},{"key":"2024041518510062300_B127","doi-asserted-by":"crossref","first-page":"e28201","DOI":"10.1371\/journal.pone.0028201","article-title":"Value of laboratory tests in employer-sponsored health risk assessments for newly identifying health conditions: analysis of 52,270 participants","volume":"6","author":"Kaufman","year":"2011","journal-title":"PLoS One"},{"key":"2024041518510062300_B128","volume-title":"Employer Health Benefits: 2006 Annual Survey.","author":"Claxton","year":"2006"},{"key":"2024041518510062300_B129","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.eprac.2021.07.001","article-title":"Impact of high deductible health plans on diabetes care quality and outcomes: systematic review","volume":"27","author":"Jiang","year":"2021","journal-title":"Endocr Pract"},{"key":"2024041518510062300_B130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11892-016-0784-9","article-title":"Taking telemedicine to the next level in diabetes population management: a review of the Endo ECHO Model","volume":"16","author":"Bouchonville","year":"2016","journal-title":"Curr Diab Rep"},{"key":"2024041518510062300_B131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11764-021-01136-1","article-title":"Pilot implementation to assess the feasibility and care team impact of an app-based interactive care plan to remotely monitor breast cancer survivors","volume":"16","author":"Stan","year":"2022","journal-title":"J Cancer Surviv"},{"key":"2024041518510062300_B132","doi-asserted-by":"crossref","first-page":"e003058","DOI":"10.1161\/JAHA.115.003058","article-title":"Information technology and lifestyle: a systematic evaluation of Internet and mobile interventions for improving diet, physical activity, obesity, tobacco, and alcohol use","volume":"5","author":"Afshin","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2024041518510062300_B133","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jacc.2016.03.472","article-title":"International mobile-health intervention on physical activity, sitting, and weight: the Stepathlon Cardiovascular Health study","volume":"67","author":"Ganesan","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2024041518510062300_B134","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIR.0000000000000232","article-title":"Current science on consumer use of mobile health for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"132","author":"Burke","year":"2015","journal-title":"Circulation"},{"key":"2024041518510062300_B135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2022.01.009","article-title":"Community-based, cluster-randomized pilot trial of a cardiovascular mHealth intervention: rationale, design, and baseline findings of the FAITH! Trial","volume":"247","author":"Brewer","year":"2022","journal-title":"Am Heart J"},{"key":"2024041518510062300_B136","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.3390\/ijerph16214144","article-title":"Addressing cardiovascular health disparities in Minnesota: establishment of a community steering committee by FAITH! (Fostering African-American Improvement in Total Health)","volume":"16","author":"Manjunath","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2024041518510062300_B137","doi-asserted-by":"crossref","first-page":"e28024","DOI":"10.2196\/28024","article-title":"Improvements in diet and physical activity-related psychosocial factors among African Americans using a mobile health lifestyle intervention to promote cardiovascular health: the FAITH! (Fostering African American Improvement in Total Health) app pilot study","volume":"9","author":"Cyriac","year":"2021","journal-title":"JMIR Mhealth Uhealth"},{"key":"2024041518510062300_B138","doi-asserted-by":"crossref","first-page":"e21450","DOI":"10.2196\/21450","article-title":"A cardiovascular health and wellness mobile health intervention among church-going African Americans: formative evaluation of the FAITH! app","volume":"4","author":"Brewer","year":"2020","journal-title":"JMIR Form Res"},{"key":"2024041518510062300_B139","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIR.0b013e3182327084","article-title":"The American Heart Association and the Million Hearts Initiative: a presidential advisory from the American Heart Association","volume":"124","author":"Tomaselli","year":"2011","journal-title":"Circulation"},{"key":"2024041518510062300_B140","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1056\/NEJMp1110421","article-title":"The \u201cMillion Hearts\u201d initiative: preventing heart attacks and strokes","volume":"365","author":"Frieden","year":"2011","journal-title":"N Engl J Med"},{"key":"2024041518510062300_B141","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.5888\/pcd14.160587","article-title":"Implementing a quality improvement collaborative to improve hypertension control and advance Million Hearts among low-income Californians, 2014\u20132015","volume":"14","author":"Backman","year":"2017","journal-title":"Prev Chronic Dis"},{"key":"2024041518510062300_B142","doi-asserted-by":"crossref","first-page":"e006021","DOI":"10.1161\/JAHA.117.006021","article-title":"Million Hearts: description of the national surveillance and modeling methodology used to monitor the number of cardiovascular events prevented during 2012\u20132016","volume":"6","author":"Ritchey","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2024041518510062300_B143","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/NHH.0000000000000480","article-title":"Integrating preventive cardiovascular healthcare into home health: a pilot study","volume":"35","author":"Lynch","year":"2017","journal-title":"Home Healthc Now"},{"key":"2024041518510062300_B144","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/PHH.0000000000000781","article-title":"An innovative network approach to coordinating a national effort to improve cardiovascular health: the case of Million Hearts","volume":"25","author":"Varda","year":"2019","journal-title":"J Public Health Manag Pract"},{"key":"2024041518510062300_B145","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10943-019-00924-5","article-title":"Assessing health needs in African American churches: a mixed-methods study","volume":"60","author":"Su","year":"2021","journal-title":"J Relig Health"},{"key":"2024041518510062300_B146","volume-title":"Mobile Integrated Healthcare and Community Paramedicine (MIH-CP): 2nd National Survey.","author":"Goodwin","year":"2018"},{"key":"2024041518510062300_B147","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.2215\/CJN.11840919","article-title":"Advancing American Kidney Health: An Introduction","volume":"14","author":"Mehrotra","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041518510062300_B148","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2215\/CJN.10560919","article-title":"A patient\u2019s perspective on Advancing American Kidney Health initiative","volume":"14","author":"Knight","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024041518510062300_B149","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/j.jrn.2019.07.004","article-title":"Implementing the \u201cAdvancing American Kidney Health Initiative\u201d by leveraging nutritional and dietary management of kidney patients","volume":"29","author":"Moore","year":"2019","journal-title":"J Ren Nutr"},{"key":"2024041518510062300_B150","author":"Federal Register"},{"key":"2024041518510062300_B151","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.kint.2022.06.012","article-title":"The next step in chronic kidney disease staging: individualized risk prediction","volume":"102","author":"Major","year":"2022","journal-title":"Kidney Int"},{"key":"2024041518510062300_B152","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1377\/hlthaff.2022.00233","article-title":"Modernizing diabetes care quality measures","volume":"41","author":"Jiang","year":"2022","journal-title":"Health Aff (Millwood)"},{"key":"2024041518510062300_B153","doi-asserted-by":"crossref","first-page":"e2029682","DOI":"10.1001\/jamanetworkopen.2020.29682","article-title":"USPSTF Recommendations for behavioral counseling in adults with cardiovascular disease risk factors: are we ready?","volume":"3","author":"Kharmats","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2024041518510062300_B154","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ypmed.2017.12.030","article-title":"Primary care providers\u2019 physical activity counseling and referral practices and barriers for cardiovascular disease prevention","volume":"108","author":"Omura","year":"2018","journal-title":"Prev Med"},{"key":"2024041518510062300_B155","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1053\/j.ajkd.2019.05.003","article-title":"Follow-up of abnormal estimated GFR results within a large integrated health care delivery system: a mixed-methods study","volume":"74","author":"Danforth","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B156","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1053\/j.ajkd.2010.08.027","article-title":"Quality of patient-physician discussions about CKD in primary care: a cross-sectional study","volume":"57","author":"Greer","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B157","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s11606-009-1086-6","article-title":"Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices","volume":"24","author":"Boulware","year":"2009","journal-title":"J Gen Intern Med"},{"key":"2024041518510062300_B158","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.ajkd.2007.12.020","article-title":"Attitudes and behaviors of African Americans regarding early detection of kidney disease","volume":"51","author":"Waterman","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2024041518510062300_B159","first-page":"100111","article-title":"Racial\/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study","volume":"6","author":"Elhussein","year":"2022","journal-title":"Lancet Reg Health Am"}],"container-title":["Clinical Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/42\/2\/274\/756088\/diaclincd230063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/clinical\/article-pdf\/42\/2\/274\/756088\/diaclincd230063.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:52:19Z","timestamp":1713192739000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/clinical\/article\/42\/2\/274\/153960\/Diabetic-Kidney-Disease-Prevention-Care-Model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":159,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,12,6]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.2337\/cd23-0063","relation":{},"ISSN":["0891-8929","1945-4953"],"issn-type":[{"value":"0891-8929","type":"print"},{"value":"1945-4953","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}